University of Kansas Medical Center (KUMC)

Westwood, Kansas 66205

1 studies enrolling now · 4 studies all time

What they study most

Advanced Adult Hepatocellular Carcinoma, Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Fallopian Tube Cancer, High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer, KEAP1 Gene Mutation, Mesothelioma, Metastatic Cancer, NFE2L2 Gene Mutation

Studies at this site

• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — Recruiting now
• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies — Completed
• Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma — Completed
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early